Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:29 AM
Ignite Modification Date:
2025-12-26 @ 1:04 AM
NCT ID:
NCT02975934
Group ID:
EG001
Title:
Abiraterone Acetate or Enzalutamide or Docetaxel (Treatment Phase)
Description:
Oral abiraterone acetate (monotherapy, given in combination with prednisone). Oral enzalutamide (monotherapy). Intravenous docetaxel (monotherapy, given in combination with prednisone or prednisolone).
Abiraterone acetate or Enzalutamide or Docetaxel: Abiraterone acetate and enzalutamide will be administered daily.
Docetaxel will be administered every 3 weeks.
Deaths Number Affected:
3
Deaths Number At Risk:
None
Serious Number Affected:
36
Serious Number At Risk:
130
Other Number Affected:
127
Other Number At Risk:
130
Study:
NCT02975934
Results Section:
NCT02975934
Adverse Events Module:
NCT02975934